Home
ANIP
ANIP News

Latest ANI Pharmaceuticals Inc. (ANIP) News on July 27, 2024

Argus Research

3 days ago

ANIP: Raising target price to $68.00

Syros (SYRS) Stock Rises More Than 35% in 3 Months: Here's Why

Zacks

9 days ago

Syros (SYRS) Stock Rises More Than 35% in 3 Months: Here's Why

Argus Research

10 days ago

ANIP: Raising target price to $67.00

MT Newswires

11 days ago

ANI Pharmaceuticals Launches L-Glutamine Oral Powder Following FDA Approval

ANI Pharmaceuticals Announces the FDA Approval and Launch of L-Glutamine Oral Powder

GlobeNewswire

12 days ago

ANI Pharmaceuticals Announces the FDA Approval and Launch of L-Glutamine Oral Powder

Argus Research

17 days ago

ANIP: Lowering target price to $64.00

MT Newswires

25 days ago

ANI Pharmaceuticals Receives FDA Approval for Naproxen Delayed-Release Tablets

ANI Pharmaceuticals Announces the FDA Approval and Launch of Naproxen Delayed-Release Tablets, USP

GlobeNewswire

25 days ago

ANI Pharmaceuticals Announces the FDA Approval and Launch of Naproxen Delayed-Release Tablets, USP

MT Newswires

a month ago

HC Wainwright Adjusts ANI Pharmaceuticals Price Target to $94 From $87, Maintains Buy Rating

Alimera (ALIM) Rises on Merger Deal With ANI Pharmaceuticals

Zacks

a month ago

Alimera (ALIM) Rises on Merger Deal With ANI Pharmaceuticals

ANI Pharmaceuticals’ CEO Nikhil Lalwani Named EY Entrepreneur Of The Year® 2024 New Jersey Award Winner

GlobeNewswire

a month ago

ANI Pharmaceuticals’ CEO Nikhil Lalwani Named EY Entrepreneur Of The Year® 2024 New Jersey Award Winner

MT Newswires

a month ago

Top Midday Gainers

Generics Player ANI Pharmaceuticals Strengthens Rare Disease Segment With $380M Alimera Sciences Deal

Benzinga

a month ago

Generics Player ANI Pharmaceuticals Strengthens Rare Disease Segment With $380M Alimera Sciences Deal

Alimera Sciences shares jump by 77% after being acquired by ANI

Pharmaceutical Technology

a month ago

Alimera Sciences shares jump by 77% after being acquired by ANI

MT Newswires

a month ago

ANI Pharmaceuticals to Acquire Alimera Sciences in $381 Million Deal

ANI Pharmaceuticals to Further Expand Rare Disease Business through Acquisition of Alimera Sciences

GlobeNewswire

a month ago

ANI Pharmaceuticals to Further Expand Rare Disease Business through Acquisition of Alimera Sciences

ANI Pharmaceuticals (NASDAQ:ANIP) shareholders are still up 77% over 3 years despite pulling back 6.5% in the past week

Simply Wall St.

a month ago

ANI Pharmaceuticals (NASDAQ:ANIP) shareholders are still up 77% over 3 years despite pulling back 6.5% in the past week

Strength Seen in Gilead (GILD): Can Its 8.5% Jump Turn into More Strength?

Zacks

a month ago

Strength Seen in Gilead (GILD): Can Its 8.5% Jump Turn into More Strength?

MT Newswires

a month ago

Ani Pharmaceuticals Insider Sold Shares Worth $1,817,663, According to a Recent SEC Filing

Implied Volatility Surging for ANI Pharmaceuticals (ANIP) Stock Options

Zacks

a month ago

Implied Volatility Surging for ANI Pharmaceuticals (ANIP) Stock Options

Engelhart Commodities Trading Partners Agrees to Acquire Trailstone, Strengthening Commitment to the Energy Transition

Business Wire

2 months ago

Engelhart Commodities Trading Partners Agrees to Acquire Trailstone, Strengthening Commitment to the Energy Transition

Delfi Meedia, a subsidiary of AS Ekspress Grupp to acquire business operations of Eesti Koolitus- ja Konverentsikeskus

GlobeNewswire

2 months ago

Delfi Meedia, a subsidiary of AS Ekspress Grupp to acquire business operations of Eesti Koolitus- ja Konverentsikeskus

Share buy-back programme - week 23

GlobeNewswire

2 months ago

Share buy-back programme - week 23

Do Scientex Berhad's (KLSE:SCIENTX) Earnings Warrant Your Attention?

Simply Wall St.

2 months ago

Do Scientex Berhad's (KLSE:SCIENTX) Earnings Warrant Your Attention?

Japan's service sector mood hits nearly 2-year low in May

Reuters

2 months ago

Japan's service sector mood hits nearly 2-year low in May

N. Korea sends more balloons as Kim's sister warns of 'new counteraction'

AFP

2 months ago

N. Korea sends more balloons as Kim's sister warns of 'new counteraction'

Enduring role of 'treasuring the past' hailed

PR Newswire

2 months ago

Enduring role of 'treasuring the past' hailed

Velcan Holdings: buyback offer of 500 000 shares at Eur 14.5 per share

GlobeNewswire

2 months ago

Velcan Holdings: buyback offer of 500 000 shares at Eur 14.5 per share

5 Reasons a Biden Second Term Could Be a Financial Disaster for Boomers

GOBankingRates

2 months ago

5 Reasons a Biden Second Term Could Be a Financial Disaster for Boomers

US solar producers could finally have a fighting chance as tariffs kick in on cheaper imports from Asia

Business Insider

2 months ago

US solar producers could finally have a fighting chance as tariffs kick in on cheaper imports from Asia

The Best Woody Perfume For Women

Insider Monkey

2 months ago

The Best Woody Perfume For Women

Microsoft unveils all-digital Xbox consoles, 'Doom' title at Games Showcase

Reuters

2 months ago

Microsoft unveils all-digital Xbox consoles, 'Doom' title at Games Showcase

Insider Monkey

2 months ago

Best Date Night Fragrance in 2024

France's Macron calls snap legislative elections after EU poll blow

AFP

2 months ago

France's Macron calls snap legislative elections after EU poll blow

Dow Jones Futures Due; Apple AI Push, Fed Rate Outlook Lead 8 Big Market Events

Investor's Business Daily

2 months ago

Dow Jones Futures Due; Apple AI Push, Fed Rate Outlook Lead 8 Big Market Events

European Union Vote Delivers Shift to Right, in Blow to French and German Governments

The Wall Street Journal

2 months ago

European Union Vote Delivers Shift to Right, in Blow to French and German Governments

Insider Sale: SVP & CFO Stephen Carey Sells 5,000 Shares of ANI Pharmaceuticals Inc (ANIP)

GuruFocus.com

2 months ago

Insider Sale: SVP & CFO Stephen Carey Sells 5,000 Shares of ANI Pharmaceuticals Inc (ANIP)

MT Newswires

2 months ago

Ani Pharmaceuticals Insider Sold Shares Worth $317,900, According to a Recent SEC Filing

MT Newswires

2 months ago

ANI Pharmaceuticals Insider Sold Shares Worth $1,288,200, According to a Recent SEC Filing

ANI Pharmaceuticals to Present at the 2024 Jefferies Global Healthcare Conference

GlobeNewswire

2 months ago

ANI Pharmaceuticals to Present at the 2024 Jefferies Global Healthcare Conference

MT Newswires

2 months ago

Ani Pharmaceuticals Insider Sold Shares Worth $794,568, According to a Recent SEC Filing

AstraZeneca (AZN) Plans to Generate $80B in Revenues by 2030

Zacks

2 months ago

AstraZeneca (AZN) Plans to Generate $80B in Revenues by 2030

Dyne (DYN) Soars 28% on New Data From Muscle Disease Studies

Zacks

2 months ago

Dyne (DYN) Soars 28% on New Data From Muscle Disease Studies

PTC Therapeutics (PTCT) Up as EC Returns CHMP Opinion on DMD Drug

Zacks

2 months ago

PTC Therapeutics (PTCT) Up as EC Returns CHMP Opinion on DMD Drug

Sanofi (SNY) Signs Deal for AI-Powered Drug Development

Zacks

2 months ago

Sanofi (SNY) Signs Deal for AI-Powered Drug Development

BeiGene's (BGNE) Shares Surge 32% in a Month: Here's Why

Zacks

2 months ago

BeiGene's (BGNE) Shares Surge 32% in a Month: Here's Why

MT Newswires

2 months ago

ANI Pharmaceuticals Launches Kionex Suspension

Has Acrivon Therapeutics, Inc. (ACRV) Outpaced Other Medical Stocks This Year?

Zacks

2 months ago

Has Acrivon Therapeutics, Inc. (ACRV) Outpaced Other Medical Stocks This Year?

Down -6.19% in 4 Weeks, Here's Why ANI (ANIP) Looks Ripe for a Turnaround

Zacks

2 months ago

Down -6.19% in 4 Weeks, Here's Why ANI (ANIP) Looks Ripe for a Turnaround

ANI Pharmaceuticals Announces the Launch of Kionex® Suspension

GlobeNewswire

2 months ago

ANI Pharmaceuticals Announces the Launch of Kionex® Suspension

Director Renee Tannenbaum Sells 2,000 Shares of ANI Pharmaceuticals Inc (ANIP)

GuruFocus.com

2 months ago

Director Renee Tannenbaum Sells 2,000 Shares of ANI Pharmaceuticals Inc (ANIP)

Eli Lilly's (LLY) Efsitora Matches Daily Insulins in A1C Control

Zacks

2 months ago

Eli Lilly's (LLY) Efsitora Matches Daily Insulins in A1C Control

Amgen's (AMGN) Tarlatamab Receives FDA Approval for SCLC

Zacks

2 months ago

Amgen's (AMGN) Tarlatamab Receives FDA Approval for SCLC

Insider Selling: President & CEO Nikhil Lalwani Sells Shares of ANI Pharmaceuticals Inc (ANIP)

GuruFocus.com

2 months ago

Insider Selling: President & CEO Nikhil Lalwani Sells Shares of ANI Pharmaceuticals Inc (ANIP)

MT Newswires

2 months ago

Ani Pharmaceuticals Insider Sold Shares Worth $1,101,821, According to a Recent SEC Filing

Kodiak (KOD) Q1 Loss Narrower Than Expected, Pipeline in Focus

Zacks

2 months ago

Kodiak (KOD) Q1 Loss Narrower Than Expected, Pipeline in Focus

Vanda (VNDA) Rises on Positive Data From Motion Sickness Study

Zacks

2 months ago

Vanda (VNDA) Rises on Positive Data From Motion Sickness Study

FDA Delays Decision on Ascendis' (ASND) Hormone Therapy Filing

Zacks

2 months ago

FDA Delays Decision on Ascendis' (ASND) Hormone Therapy Filing

Allogene (ALLO) Q1 Earnings in Line With Estimates, Sales Lag

Zacks

2 months ago

Allogene (ALLO) Q1 Earnings in Line With Estimates, Sales Lag

Novo Nordisk (NVO) Up 3% as Haemophilia Drug Meets Study Goals

Zacks

2 months ago

Novo Nordisk (NVO) Up 3% as Haemophilia Drug Meets Study Goals

Merck (MRK) Ends Keytruda Combo Melanoma Study Due to Futility

Zacks

2 months ago

Merck (MRK) Ends Keytruda Combo Melanoma Study Due to Futility

ANI Pharmaceuticals, Inc. Just Beat EPS By 459%: Here's What Analysts Think Will Happen Next

Simply Wall St.

2 months ago

ANI Pharmaceuticals, Inc. Just Beat EPS By 459%: Here's What Analysts Think Will Happen Next

GuruFocus.com

2 months ago

ANI Pharmaceuticals Inc (ANIP) Q1 2024 Earnings Call Transcript Highlights: Robust Growth and ...

ANI Pharmaceuticals, Inc. (NASDAQ:ANIP) Q1 2024 Earnings Call Transcript

Insider Monkey

3 months ago

ANI Pharmaceuticals, Inc. (NASDAQ:ANIP) Q1 2024 Earnings Call Transcript

ANI Pharmaceuticals First Quarter 2024 Earnings: Beats Expectations

Simply Wall St.

3 months ago

ANI Pharmaceuticals First Quarter 2024 Earnings: Beats Expectations

ANI Pharmaceuticals Reports Strong Q1 2024 Results, Surpassing Revenue Expectations

GuruFocus.com

3 months ago

ANI Pharmaceuticals Reports Strong Q1 2024 Results, Surpassing Revenue Expectations

Nektar's (NKTR) Q1 Earnings and Revenues Surpass Estimates

Zacks

3 months ago

Nektar's (NKTR) Q1 Earnings and Revenues Surpass Estimates

Insmed (INSM) Beats on Q1 Earnings, Posts Upbeat Pipeline Updates

Zacks

3 months ago

Insmed (INSM) Beats on Q1 Earnings, Posts Upbeat Pipeline Updates

Iovance (IOVA) Q1 Earnings Surpass, Sales Lag Estimates

Zacks

3 months ago

Iovance (IOVA) Q1 Earnings Surpass, Sales Lag Estimates

Amicus (FOLD) Q1 Earnings Top, Sales Lag, '24 Outlook Updated

Zacks

3 months ago

Amicus (FOLD) Q1 Earnings Top, Sales Lag, '24 Outlook Updated

ANI (ANIP) Q1 Earnings: Taking a Look at Key Metrics Versus Estimates

Zacks

3 months ago

ANI (ANIP) Q1 Earnings: Taking a Look at Key Metrics Versus Estimates

Xenon (XENE) Q1 Earnings Beat Estimates, Pipeline in Focus

Zacks

3 months ago

Xenon (XENE) Q1 Earnings Beat Estimates, Pipeline in Focus

MT Newswires

3 months ago

ANI Pharmaceuticals Q1 Adjusted Earnings, Revenue Rise; Reaffirms Full Year 2024 Earnings, Revenue Guidance

Associated Press Finance

3 months ago

ANI: Q1 Earnings Snapshot

ANI Pharmaceuticals Reports Record First Quarter 2024 Financial Results and Reiterates 2024 Guidance

GlobeNewswire

3 months ago

ANI Pharmaceuticals Reports Record First Quarter 2024 Financial Results and Reiterates 2024 Guidance

Catalyst (CPRX) Q1 Earnings Beat, Firdapse Sales Drive Revenues

Zacks

3 months ago

Catalyst (CPRX) Q1 Earnings Beat, Firdapse Sales Drive Revenues

Why Earnings Season Could Be Great for ANI Pharmaceuticals (ANIP)

Zacks

3 months ago

Why Earnings Season Could Be Great for ANI Pharmaceuticals (ANIP)

ANI Pharmaceuticals, Inc. (NASDAQ:ANIP) Stock Is Going Strong But Fundamentals Look Uncertain: What Lies Ahead ?

Simply Wall St.

3 months ago

ANI Pharmaceuticals, Inc. (NASDAQ:ANIP) Stock Is Going Strong But Fundamentals Look Uncertain: What Lies Ahead ?

Acadia (ACAD) Q1 Earnings Surpass Estimates, Revenues Miss

Zacks

3 months ago

Acadia (ACAD) Q1 Earnings Surpass Estimates, Revenues Miss

Esperion (ESPR) Q1 Earnings Beat, Stock Up on Strong Revenues

Zacks

3 months ago

Esperion (ESPR) Q1 Earnings Beat, Stock Up on Strong Revenues

Intra-Cellular (ITCI) Q1 Earnings and Sales Beat Estimates

Zacks

3 months ago

Intra-Cellular (ITCI) Q1 Earnings and Sales Beat Estimates

Pacira (PCRX) Q1 Earnings Miss, Exparel Sales Drive Revenues

Zacks

3 months ago

Pacira (PCRX) Q1 Earnings Miss, Exparel Sales Drive Revenues

Rocket's (RCKT) Q1 Loss Narrower Than Expected, Sales Nil

Zacks

3 months ago

Rocket's (RCKT) Q1 Loss Narrower Than Expected, Sales Nil

Apellis' (APLS) Q1 Earnings Match Estimates, Revenues Beat

Zacks

3 months ago

Apellis' (APLS) Q1 Earnings Match Estimates, Revenues Beat

ANI Pharmaceuticals (ANIP) to Post Q1 Earnings: What's in Store?

Zacks

3 months ago

ANI Pharmaceuticals (ANIP) to Post Q1 Earnings: What's in Store?

MT Newswires

3 months ago

Ani Pharmaceuticals Insider Sold Shares Worth $1,332,400, According to a Recent SEC Filing

Agios (AGIO) Q1 Earnings Surpass, Sales Miss Estimates

Zacks

3 months ago

Agios (AGIO) Q1 Earnings Surpass, Sales Miss Estimates

ANI Pharmaceuticals (ANIP) Expected to Beat Earnings Estimates: What to Know Ahead of Q1 Release

Zacks

3 months ago

ANI Pharmaceuticals (ANIP) Expected to Beat Earnings Estimates: What to Know Ahead of Q1 Release

Blueprint (BPMC) Q1 Earnings and Revenues Beat, Stock Rises

Zacks

3 months ago

Blueprint (BPMC) Q1 Earnings and Revenues Beat, Stock Rises

Is Amarin (AMRN) Stock Outpacing Its Medical Peers This Year?

Zacks

3 months ago

Is Amarin (AMRN) Stock Outpacing Its Medical Peers This Year?

Moderna (MRNA) Q1 Earnings Beat Estimates, Revenues Down Y/Y

Zacks

3 months ago

Moderna (MRNA) Q1 Earnings Beat Estimates, Revenues Down Y/Y

ANI Pharmaceuticals to Participate at Two Upcoming Healthcare Conferences

GlobeNewswire

3 months ago

ANI Pharmaceuticals to Participate at Two Upcoming Healthcare Conferences

GSK Beats Q1 Earnings & Sales Estimates, Ups 2024 Guidance

Zacks

3 months ago

GSK Beats Q1 Earnings & Sales Estimates, Ups 2024 Guidance

How to Boost Your Portfolio with Top Medical Stocks Set to Beat Earnings

Zacks

3 months ago

How to Boost Your Portfolio with Top Medical Stocks Set to Beat Earnings

Sage Therapeutics (SAGE) Q1 Earnings Miss, Sales Beat Estimates

Zacks

3 months ago

Sage Therapeutics (SAGE) Q1 Earnings Miss, Sales Beat Estimates

Argus Research

3 months ago

ANIP: What does Argus have to say about ANIP?

ANI Pharmaceuticals to Discuss First Quarter 2024 Financial Results on May 10, 2024, at 8:30 a.m. ET

GlobeNewswire

3 months ago

ANI Pharmaceuticals to Discuss First Quarter 2024 Financial Results on May 10, 2024, at 8:30 a.m. ET

Sage (SAGE) Down 20% on Parkinson's Study Missing Primary Goal

Zacks

3 months ago

Sage (SAGE) Down 20% on Parkinson's Study Missing Primary Goal

GSK Announces FDA Acceptance of New Meningococcal Jab BLA

Zacks

3 months ago

GSK Announces FDA Acceptance of New Meningococcal Jab BLA

Aptevo (APVO) Stock Plummets 79% in a Week: Here's Why

Zacks

3 months ago

Aptevo (APVO) Stock Plummets 79% in a Week: Here's Why

Share on Social Networks: